S

Pre-Market Most Active for Jun 5, 2014 : RAD, S, RCAP, AUY, ALU, CIEN, QQQ, XIV, HALO, FB, ZNGA, MRVL

Shutterstock photo

The NASDAQ 100 Pre-Market Indicator is up 7.04 to 3,750.63. The total Pre-Market volume is currently 5,246,122 shares traded.

The following are the most active stocks for the pre-market session :

Rite Aid Corporation ( RAD ) is -0.67 at $7.83, with 3,274,424 shares traded., following a 52-week high recorded in prior regular session.

Sprint Corporation ( S ) is +0.14 at $9.54, with 1,777,317 shares traded. S's current last sale is 119.25% of the target price of $8.

RCS CAPITAL CORPORATION ( RCAP ) is -1.45 at $21.15, with 1,280,277 shares traded. As reported by Zacks, the current mean recommendation for RCAP is in the "strong buy range".

Yamana Gold Inc. ( AUY ) is unchanged at $7.35, with 959,793 shares traded. As reported by Zacks, the current mean recommendation for AUY is in the "buy range".

Alcatel Lucent ( ALU ) is +0.08 at $3.92, with 769,182 shares traded. ALU's current last sale is 87.11% of the target price of $4.5.

Ciena Corporation ( CIEN ) is +2.66 at $21.65, with 614,462 shares traded. RTT News Reports: Ciena Q2 Loss Narrows, Results Top Estimates

PowerShares QQQ Trust, Series 1 ( QQQ ) is +0.25 at $91.77, with 338,676 shares traded., following a 52-week high recorded in prior regular session.

Credit Suisse AG ( XIV ) is +0.49 at $39.91, with 236,495 shares traded., following a 52-week high recorded in prior regular session.

Halozyme Therapeutics, Inc. ( HALO ) is +1.22 at $9.30, with 217,298 shares traded. HALO's current last sale is 77.5% of the target price of $12.

Facebook, Inc. ( FB ) is +0.24 at $63.58, with 215,390 shares traded. As reported by Zacks, the current mean recommendation for FB is in the "buy range".

Zynga Inc. ( ZNGA ) is -0.02 at $3.25, with 211,922 shares traded. ZNGA's current last sale is 78.79% of the target price of $4.125.

Marvell Technology Group Ltd. ( MRVL ) is -0.57 at $15.45, with 188,250 shares traded. Over the last four weeks they have had 6 up revisions for the earnings forecast, for the fiscal quarter ending Jul 2014. The consensus EPS forecast is $0.22. MRVL's current last sale is 90.88% of the target price of $17.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.